BCHMF:OTC-Bachem Holding AG (USD)

COMMON STOCK | Chemicals |

Last Closing

USD 91.7732

Change

0.00 (0.00)%

Market Cap

USD 6.88B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-03 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
SHECF Shin-Etsu Chemical Co. Ltd

N/A

USD 74.34B
SHECY Shin-Etsu Chemical Co Ltd ADR

N/A

USD 72.60B
BFFAF BASF SE NA O.N.

N/A

USD 43.27B
SLMNP A. Schulman Inc

N/A

USD 27.44B
TYNPF Nippon Sanso Holdings Corporat..

N/A

USD 15.30B
AHKSY Asahi Kaisei Corp

N/A

USD 10.28B
GNENY Ganfeng Lithium Co. Ltd

N/A

USD 8.88B
GNENF Ganfeng Lithium Co Ltd

N/A

USD 8.62B
NNCHF Nissan Chemical Corporation

N/A

USD 4.66B
SVYSF Solvay SA

N/A

USD 4.36B

ETFs Containing BCHMF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.10% 68% D+ 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.10% 68% D+ 58% F
Trailing 12 Months  
Capital Gain 8.10% 67% D+ 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.10% 67% D+ 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.01% 62% D 46% F
Dividend Return 5.18% 56% F 43% F
Total Return 0.17% 14% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 8.66% 98% N/A 97% N/A
Risk Adjusted Return 59.83% 92% A 90% A-
Market Capitalization 6.88B 71% C- 88% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.